Surrozen company info

What does Surrozen do?
Surrozen (NASDAQ:SRZN) is a biotechnology company engaged in discovering and developing novel therapies aimed at regenerating tissues in the body. With a focus on leveraging the Wnt signaling pathway, a key regulator of tissue regeneration and repair, Surrozen is dedicated to addressing a wide range of diseases and conditions. The company's innovative approach involves creating bi-specific antibodies designed to selectively activate tissue repair in specific organs without affecting tissues elsewhere in the body. Surrozen's projects include developing treatments for liver diseases, inflammatory bowel disease, and various other conditions that currently have limited therapeutic options. The company's objective is to transform the landscape of regenerative medicine by offering new, more effective therapies that can promote organ regeneration and repair, thereby improving the quality of life for patients with debilitating diseases.
Surrozen company media
Company Snapshot

Is Surrozen a public or private company?

key
Ownership
Public

How many people does Surrozen employ?

people
Employees
42

What sector is Surrozen in?

pie chart
Sector
Health Care

Where is the head office for Surrozen?

location pin
Head Office
South San Francisco, United States

What year was Surrozen founded?

founded flag
Year Founded
2015
What does Surrozen specialise in?
/Wnt Pathway /Regenerative Medicine /Therapeutic Antibodies /Liver Diseases /Biotechnology Research /Drug Development

What are the products and/or services of Surrozen?

Overview of Surrozen offerings
Developing Wnt signal pathway modulators for regenerative medicine, focusing on liver diseases.
Creating drugs to address broad chronic and acute gastrointestinal disorders using tissue repair technologies.
Advancing treatments for serious eye diseases by targeting Wnt signaling pathways.
Exploring Wnt pathway modulators for potential applications in lung disease and regeneration.
Pioneering innovative therapies for skin disorders and wound healing through Wnt signaling modulation.
Researching applications of their technology in regenerative orthopedics to address bone and cartilage repair.

Who is in the executive team of Surrozen?

Surrozen leadership team
  • Mr. Craig C. Parker M.B.A.
    Mr. Craig C. Parker M.B.A.
    CEO, President & Director
  • Mr. Charles  Williams
    Mr. Charles Williams
    CFO, COO & Corporate Secretary
  • Dr. K. Christopher  Garcia Ph.D.
    Dr. K. Christopher Garcia Ph.D.
    Co-Founder & Member of Scientific Advisory Board
  • Dr. Roeland  Nusse Ph.D.
    Dr. Roeland Nusse Ph.D.
    Co-Founder & Member of Scientific Advisory Board
  • Dr. Calvin  Kuo M.D., Ph.D.
    Dr. Calvin Kuo M.D., Ph.D.
    Co-Founder & Member of Scientific Advisor
  • Dr. Li  Yang Ph.D.
    Dr. Li Yang Ph.D.
    Executive Vice President of Research
  • Esther  Jhun
    Esther Jhun
    Controller